Page last updated: 2024-11-13

tetracarboxyphenylporphine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID86278368
CHEMBL ID374342
SCHEMBL ID709532
MeSH IDM0069869

Synonyms (47)

Synonym
4-[(1z,4z,9z,15z)-10,15,20-tris(4-carboxyphenyl)-21,23-dihydroporphyrin-5-yl]benzoic acid
meso-tetra(4-carboxyphenyl)porphine
14609-54-2
5,10,15,20-tetrakis(4-carboxyphenyl)-21h,23h-porphine
mtcpp
4,4',4'',4'''-(porphine-5,10,15,20-tetrayl)tetrakis(benzoic acid), dye content 75 %
tetrakis(4-carboxyphenyl)porphyrin
tetracarboxyphenylporphine
CHEMBL374342 ,
e9892w6imc ,
unii-e9892w6imc
meso-tetra-(4-carboxyphenyl)porphine
ccris 8701
hsdb 8470
benzoic acid, 4,4',4'',4'''-(21h,23h-porphine-5,10,15,20-tetrayl)tetrakis-
SCHEMBL709532
J207.982H ,
5,10,15,20-tetra(4-carboxyphenyl)porphine
tetra(4-carboxyphenyl)porphine
HHDUMDVQUCBCEY-UHFFFAOYSA-N
4,4,4,4-(porphine-5,10,15,20-tetrayl)tetrakis(benzoic acid)
meso-tetraphenylporphine-4,4',4'',4'''-tetracarboxylic acid
meso-tetra(4-carboxyphenyl)porphyrin
cypath
5,10,15,20-tetrakis(4-carboxyphenyl)porphyrin
5,10,15,20-tetrakis(4-carboxyphenyl)porphine
tcpp (porphine derivative)
benzoic acid, 4,4',4'',4'''-(5,10,15,20-porphinetetrayl)tetra-
mfcd00064860
AKOS027320385
tetrakis (4-carboxyphenyl) porphyrin
nickel ionophore ii, selectophore(tm), function tested
bdbm50247530
4-[10,15,20-tris(4-carboxyphenyl)-21,23-dihydroporphyrin-5-yl]benzoic acid
SY014907
4,4 inverted exclamation mark ,4 inverted exclamation mark inverted exclamation mark ,4 inverted exclamation mark inverted exclamation mark inverted exclamation mark -(porphine-5,10,15,20-tetrayl)tetrakis(benzoic acid)
CS-W009568
DS-11293
BCP10890
AMY11695
Q27277036
YSZC167
A884555
F14788
HY-W008852
4-[7,12,17-tris(4-carboxyphenyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3(24),4,6,8,10,12,14,16(22),17,19-undecaen-2-yl]benzoic acid
EN300-6743654
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA topoisomerase 1Homo sapiens (human)EC50 (µMol)1.28900.05000.33592.0150AID1472923; AID1472924
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (11)

Processvia Protein(s)Taxonomy
DNA topological changeDNA topoisomerase 1Homo sapiens (human)
chromatin remodelingDNA topoisomerase 1Homo sapiens (human)
circadian rhythmDNA topoisomerase 1Homo sapiens (human)
response to xenobiotic stimulusDNA topoisomerase 1Homo sapiens (human)
programmed cell deathDNA topoisomerase 1Homo sapiens (human)
phosphorylationDNA topoisomerase 1Homo sapiens (human)
peptidyl-serine phosphorylationDNA topoisomerase 1Homo sapiens (human)
circadian regulation of gene expressionDNA topoisomerase 1Homo sapiens (human)
embryonic cleavageDNA topoisomerase 1Homo sapiens (human)
chromosome segregationDNA topoisomerase 1Homo sapiens (human)
DNA replicationDNA topoisomerase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (13)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA bindingDNA topoisomerase 1Homo sapiens (human)
chromatin bindingDNA topoisomerase 1Homo sapiens (human)
double-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
single-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
RNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA topoisomerase type I (single strand cut, ATP-independent) activityDNA topoisomerase 1Homo sapiens (human)
protein serine/threonine kinase activityDNA topoisomerase 1Homo sapiens (human)
protein bindingDNA topoisomerase 1Homo sapiens (human)
ATP bindingDNA topoisomerase 1Homo sapiens (human)
DNA binding, bendingDNA topoisomerase 1Homo sapiens (human)
protein domain specific bindingDNA topoisomerase 1Homo sapiens (human)
supercoiled DNA bindingDNA topoisomerase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
nuclear chromosomeDNA topoisomerase 1Homo sapiens (human)
P-bodyDNA topoisomerase 1Homo sapiens (human)
fibrillar centerDNA topoisomerase 1Homo sapiens (human)
male germ cell nucleusDNA topoisomerase 1Homo sapiens (human)
nucleusDNA topoisomerase 1Homo sapiens (human)
nucleoplasmDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
perikaryonDNA topoisomerase 1Homo sapiens (human)
protein-DNA complexDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1845447Photocytotoxicity against human WiDr cells assessed as lethal dose incubated for 18 hrs followed by replacement of medium containing compound with 48 hrs incubation and subsequent light irradiation of 13.5 mW/cm2 at 435 nm measured after 48 hrs by MTT ass2021Bioorganic & medicinal chemistry, 01-15, Volume: 30Porphyrin and phthalocyanine photosensitizers designed for targeted photodynamic therapy of colorectal cancer.
AID1472923Inhibition of recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells using supercoiled pBS SK(+) DNA as substrate after 15 mins by ethidium bromide staining based agarose gel electrophoresis method2018Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3
Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.
AID1472924Inhibition of recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells using supercoiled pBS SK(+) DNA as substrate preincubated for 5 mins followed by substrate addition measured after 15 mins by ethidium bromide staining based agaro2018Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3
Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (69)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (7.25)18.7374
1990's8 (11.59)18.2507
2000's13 (18.84)29.6817
2010's29 (42.03)24.3611
2020's14 (20.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.69 (24.57)
Research Supply Index4.28 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other71 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]